Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Inhaled Beclomethasone on Lung Gene Expression in Healthy Smokers
NCT00532584Phase 4Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2011
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of beclomethasone in chronic obstructive pulmonary disease (COPD), sponsored by Weill Cornell Medicine. Planned start Feb 2011; status: withdrawn.
02
Drugs
beclomethasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00532584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532584.